Hosted on MSN

Standard BioTools outlines $165M-$175M revenue target for FY2025 while driving proteomics partnerships

CEO Michael Egholm highlighted that Standard BioTools delivered Q1 2025 revenues of $40.8 million, aligned with their plan despite a challenging operating backdrop. He emphasized improvements in ...
Seeking Alpha

Standard BioTools: Too Early To Determine The Fate Of This Turnaround

Standard BioTools, is engaged in product rationalization, cost-cutting and operational efficiency measures in an attempt to turn its business around and transition to profitability. The company’s ...